Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Sold by Kolinsky Wealth Management LLC

Kolinsky Wealth Management LLC lessened its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 19.5% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 703 shares of the medical equipment provider’s stock after selling 170 shares during the quarter. Kolinsky Wealth Management LLC’s holdings in Intuitive Surgical were worth $367,000 as of its most recent SEC filing.

Several other institutional investors have also recently added to or reduced their stakes in the stock. PharVision Advisers LLC purchased a new position in Intuitive Surgical in the 4th quarter valued at approximately $676,000. Mpwm Advisory Solutions LLC acquired a new stake in shares of Intuitive Surgical in the fourth quarter valued at approximately $57,000. Principal Street Partners LLC acquired a new position in Intuitive Surgical in the fourth quarter valued at $253,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its position in Intuitive Surgical by 12.8% during the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 2,826,972 shares of the medical equipment provider’s stock worth $1,475,566,000 after acquiring an additional 319,694 shares during the period. Finally, Worldquant Millennium Advisors LLC purchased a new position in Intuitive Surgical in the 4th quarter valued at $1,775,000. Institutional investors and hedge funds own 83.64% of the company’s stock.

Intuitive Surgical Price Performance

ISRG opened at $557.16 on Wednesday. The business has a 50 day moving average price of $508.11 and a two-hundred day moving average price of $537.36. The company has a market capitalization of $199.70 billion, a price-to-earnings ratio of 86.92, a price-to-earnings-growth ratio of 5.85 and a beta of 1.70. Intuitive Surgical, Inc. has a 1-year low of $396.15 and a 1-year high of $616.00.

Intuitive Surgical (NASDAQ:ISRG) last announced its earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share for the quarter, beating the consensus estimate of $1.71 by $0.10. Intuitive Surgical had a return on equity of 14.55% and a net margin of 27.81%. The business had revenue of $2.25 billion during the quarter, compared to analysts’ expectations of $2.19 billion. During the same quarter last year, the business posted $1.50 earnings per share. Equities analysts expect that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

ISRG has been the subject of several recent analyst reports. Evercore ISI reduced their price objective on shares of Intuitive Surgical from $510.00 to $470.00 and set an “in-line” rating for the company in a research note on Wednesday, April 23rd. Raymond James increased their price objective on shares of Intuitive Surgical from $560.00 to $688.00 and gave the company an “outperform” rating in a research note on Friday, January 24th. Royal Bank of Canada cut their price target on Intuitive Surgical from $630.00 to $605.00 and set an “outperform” rating for the company in a report on Wednesday, April 23rd. Piper Sandler reduced their price objective on shares of Intuitive Surgical from $670.00 to $575.00 and set an “overweight” rating on the stock in a research note on Wednesday, April 23rd. Finally, BTIG Research set a $560.00 price objective on Intuitive Surgical and gave the company a “buy” rating in a research report on Monday, April 14th. Five equities research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $598.95.

Insider Transactions at Intuitive Surgical

In related news, EVP Brian Edward Miller sold 8,900 shares of the stock in a transaction dated Tuesday, March 11th. The stock was sold at an average price of $485.07, for a total value of $4,317,123.00. Following the completion of the sale, the executive vice president now directly owns 5,758 shares of the company’s stock, valued at approximately $2,793,033.06. This represents a 60.72% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CFO Jamie Samath sold 188 shares of Intuitive Surgical stock in a transaction dated Friday, February 28th. The shares were sold at an average price of $566.94, for a total value of $106,584.72. Following the transaction, the chief financial officer now directly owns 7,162 shares in the company, valued at approximately $4,060,424.28. This trade represents a 2.56% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 32,700 shares of company stock valued at $16,865,621 in the last quarter. Insiders own 0.70% of the company’s stock.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.